Nextage Therapeutics Ltd
Nextage Therapeutics Ltd
Share · IL0004330119 (XTAE)
Overview
No Price
n/a
Share Float & Liquidity
Free Float 6,97 %
Shares Float 5,65 M
Shares Outstanding 81,06 M
Company Profile for Nextage Therapeutics Ltd Share
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
Get up to date insights from finAgent about Nextage Therapeutics Ltd

Company Data

Name Nextage Therapeutics Ltd
Company Nextage Therapeutics Ltd
Website https://www.nxtg.co.il
Primary Exchange XTAE TASE
ISIN IL0004330119
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Abraham Dreazen
Market Capitalization 63 Mio
Country Israel
Currency ILA
Employees 0,0 T
Address Einstein St. Building 13B, 4147 Ness Ziona
IPO Date 2002-08-12

Ticker Symbols

Name Symbol
TASE NXTG.TA
More Shares
Investors who hold Nextage Therapeutics Ltd also have the following shares in their portfolio:
BOOKING  20/25
BOOKING 20/25 Bond
FOSSE MASTER ISSUER PLC CLS A6 RES BKD NTS 18/10/2054 (144A)
FOSSE MASTER ISSUER PLC CLS A6 RES BKD NTS 18/10/2054 (144A) Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025